 |
|
Percutaneous Absorption of Topically Applied Triamcinolone in Children
James E. Rasmussen, MD
Arch Dermatol. 1978;114(8):1165-1167.
Abstract
• The real and potential problems associated with the percutaneous absorption of topically applied corticosteroids have been used as an argument against the prolonged administration of these drugs. Many pediatricians and dermatologists consider children to be more likely to absorb substantial quantities of topically applied corticosteroids than adults. This study examines the percutaneous absorption of 0.1% triamcinolone acetonide ointment applied four times a day for a period of six weeks to patients with severe atopic eczema. The results of 8 AM and 4 PM plasma cortisol and 24-hour urinary cortisol determinations do not indicate any notable adrenal suppression. No patient had an 8 AM cortisol value that would be considered in the abnormal range. These results indicate that the use of a mediumstrength topical corticosteroid for this length of time probably poses no noteworthy hazard from percutaneous absorption.
(Arch Dermatol 114:1165-1167, 1978)
Author Affiliations
From the Departments of Dermatology, State University of New York at Buffalo and Children's Hospital of Buffalo.
Footnotes
Accepted for publication April 11, 1978.
Reprint requests to Children's Hospital of Buffalo, 219 Bryant St, Buffalo, NY 14222 (Dr Rasmussen).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Management of Atopic Dermatitis in the Pediatric Population
Krakowski et al.
Pediatrics 2008;122:812-824.
ABSTRACT
| FULL TEXT
Once-Daily vs Twice-Daily Triamcinolone Acetonide Cream for Psoriasis
Kanzler et al.
Arch Dermatol 2001;137:1529-1531.
FULL TEXT
Hypothalamic-Pituitary-Adrenal Function and Glucocorticoid Sensitivity in Atopic Dermatitis
Ellison et al.
Pediatrics 2000;105:794-799.
ABSTRACT
| FULL TEXT
|
